Management of anastomotic leakage in upper gastrointestinal tract after oncologic surgery: Role of fully covered metallic stents
World Journal of Gastroenterology · 28.08.2026 · 32 (32)
DOI: 10.3748/wjg.119202 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 28.08.2026. Verfasst von Margarida Saraiva und 11 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Upper gastrointestinal anastomotic leakage (AL) is a life-threatening condition with high mortality rates and one of the most feared complications following surgery. Due to its challenging clinical management, a multidisciplinary approach is recommended. In the last decades, endoscopic devices and technical advancements have provided less invasive therapeutic alternatives to surgery. However, evidence on the best approach is still lacking. This study investigated the efficacy of fully covered self-expandable metallic stents (FCSEMS) in upper gastrointestinal tract AL management, in the oncology setting. AIM To evaluate the clinical effectiveness of FCSEMS in managing upper gastrointestinal AL after oncologic surgery. METHODS A retrospective cohort study was conducted at a tertiary care hospital. From December 2013 to December 2023, all consecutive patients who developed AL after upper gastrointestinal oncologic surgery and were treated with FCSEMS were included in the study. We analyzed clinical data, leakage characteristics, FCSEMS technical and clinical success, stent-related complications, and mortality. RESULTS A total of 70 patients (80% male, median age 65.5 years) were included. Surgery was performed due to esophageal (25.7%), esophagogastric junction (47.1%), and gastric (27.1%) cancers. Neoadjuvant treatment was administered in 68.6% patients; Ivor-Lewis esophagectomy (30%), McKeown esophagectomy (22.9%), and total gastrectomy (42.9%) were the most common surgeries. Intensive care unit admission occurred in 48.6%, and external drainage in 88.6%. Leakage size was < 20 mm in 80%; neoadjuvant therapy was associated with larger leaks (P = 0.029). Stent migration occurred in 31 cases. The average number of FCSEMS per patient was 1.5 (1-4); neoadjuvant therapy was associated with a higher number of stents (P = 0.011). Technical success was achieved in 95.7% of cases, with clinical success in 57 (81.4%) patients. CONCLUSION FCSEMS offer effective management of AL in the upper gastrointestinal tract. Specifically for oncological AL, their placement should be considered due to their high technical and clinical success rates.
Zitieren
APA
Saraiva, M., Conceição, D., Gomes, L. C., Garcia, J. L., Currais, P., Simões, C., Moleiro, J., Lage, P., Ramos, P., Monteiro, C., Casaca, R., & Rosa, I. (2026). Management of anastomotic leakage in upper gastrointestinal tract after oncologic surgery: Role of fully covered metallic stents. World Journal of Gastroenterology, 32(32). https://doi.org/10.3748/wjg.119202
Vancouver
Saraiva M, Conceição D, Gomes LC, Garcia JL, Currais P, Simões C, et al. Management of anastomotic leakage in upper gastrointestinal tract after oncologic surgery: Role of fully covered metallic stents. World Journal of Gastroenterology. 2026;32(32). doi:10.3748/wjg.119202
BibTeX
@article{Saraiva2026,
author = {Saraiva, Margarida and Conceição, Daniel and Gomes, Luís Correia and Garcia, Joana Lemos and Currais, Pedro and Simões, Carolina and Moleiro, Joana and Lage, Pedro and Ramos, Paulo and Monteiro, Cecília and Casaca, Rui and Rosa, Isadora},
title = {Management of anastomotic leakage in upper gastrointestinal tract after oncologic surgery: Role of fully covered metallic stents},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {32},
doi = {10.3748/wjg.119202}
}
EUVIMED